Pharma is currently facing various challenges including low R&D productivity and competition from generic drugs. Instead, Biotech suffers from lack of funding more than ever as markets become more and more cautious with sectors showing a high risk profile.

Biostrategy Analytics’s mission is to provide Pharma/Biotech companies with pragmatic analyses and deep insights into the industry.